Suggested risk factor for oral lichen planus arising after mRNA COVID-19 vaccination.

Published in: Clinical case reports (2022)

A single dose of BNT162b2 vaccine is suggested for COVID-19-infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).

Keyphrases

coronavirus disease
sars cov
oxidative stress
respiratory syndrome coronavirus
rare case